{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:07:55Z","timestamp":1795104475529,"version":"4.10.3"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has significantly increased in recent years. GLP-1 RAs delay gastric emptying, resulting in early satiety and weight loss. This may increase the risk of pulmonary aspiration of residual gastric contents (RGC) during anesthesia delivery. Evidence is urgently needed to guide perioperative anesthesia management for patients taking GLP-1 RAs. This study evaluated preoperative factors that may be associated with high RGC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Adult patients who were taking GLP-1 RAs and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS). The primary outcome was high RGC, defined by the presence of solids food or &gt;1.5 mL\/kg of clear liquids on GUS, and its association with preoperative factors (eg, existing medical conditions, indication and route of taking GLP-1 RAs, length of taking GLP-1 RAs, days of withholding GLP-1 RAs before surgery, and preoperative fasting periods). Data are presented as median (interquartile range [IQR]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Among the 316 patients (60.9 years [52.1\u201368.9] of age; 167 [52.8%] females) included in the study, 113 (35.8%) had high RGC. A higher percentage (5.3%; 6\/113) of patients in the high RGC group had an opioid prescription for pain management within 3 months of the GUS assessment compared to the low RGC group (1.0%; 2\/203;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .027). No statistical difference was found between the groups in other existing medical conditions, indication and route of taking GLP-1 RAs, and length of taking GLP-1 RAs. Of the 294 patients taking weekly injections, there were 187 (63.6%) with low RGC and 107 (36.4%) with high RGC. Patients with low RGC withheld their GLP-1 RAs for 8 days [5\u201310], while patients with high RGC withheld for 6 days [3\u20139] (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .003). Receiver operating characteristic (ROC) analysis found \u22647.5 days of withholding the medication as cutoff for increased prevalence of high RGC in patients taking GLP-1 RA injections. Patients with low RGC fasted from solid food for 20.0 hours [14.8\u201340.8], and patients with high RGC fasted from solid food for 15.0 hours [12.8\u201319.0] (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). ROC found \u226421.3 hours of fasting from solid food as the cutoff for increased prevalence of high RGC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>GLP-1 RA usage may delay gastric emptying. In preoperatively fasting adults, \u22647.5 days of withholding injections and \u226421.3 hours of fasting from solid food are associated with high RGC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007764","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:00:09Z","timestamp":1759341609000},"page":"640-649","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia"],"prefix":"10.1213","volume":"142","author":[{"given":"Sher-Lu","family":"Pai","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhuja R.","family":"Nimma","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Brian","family":"Beam","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"VanderWielen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari K.","family":"Kalagara","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layne M.","family":"Bettini","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Sharpe","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica W.","family":"Harbell","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MAGIC (Mayo Anesthesia Gastric Imaging Collaborative) Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"suppl 2","key":"R2-20260331","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"R3-20260331","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s40140-024-00611-6","article-title":"Perioperative considerations for patients on semaglutide.","volume":"14","author":"Pai","year":"2024","journal-title":"Curr Anesthesiol Rep"},{"key":"R4-20260331","first-page":"69","article-title":"Are serious anesthesia risks of semaglutide and other GLP-1 agonists under-recognized? Case reports of retained solid gastric contents in patients undergoing anesthesia.","volume":"38","author":"Beam","year":"2023","journal-title":"APSF Newsletter"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.","volume":"70","author":"Gulak","year":"2023","journal-title":"Can J Anaesth"},{"key":"R6-20260331","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.","volume":"70","author":"Klein","year":"2023","journal-title":"Can J Anaesth"},{"key":"R7-20260331","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.","volume":"71","author":"Wu","year":"2024","journal-title":"Can J Anaesth"},{"key":"R8-20260331","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia.","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"R9-20260331","doi-asserted-by":"crossref","first-page":"111091","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy.","volume":"87","author":"Silveira","year":"2023","journal-title":"J Clin Anesth"},{"key":"R10-20260331","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide.","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can J Anaesth"},{"key":"R11-20260331","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.","volume":"14","author":"Kobori","year":"2023","journal-title":"J Diabetes Investig"},{"key":"R12-20260331","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD).","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R13-20260331","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R14-20260331","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R15-20260331","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/aeu151","article-title":"Ultrasound assessment of gastric content and volume.","volume":"113","author":"Van de Putte","year":"2014","journal-title":"Br J Anaesth"},{"key":"R16-20260331","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1213\/ANE.0b013e318274fc19","article-title":"Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination.","volume":"116","author":"Perlas","year":"2013","journal-title":"Anesth Analg"},{"key":"R17-20260331","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1213\/ANE.0000000000003372","article-title":"Diagnostic accuracy of point-of-care gastric ultrasound.","volume":"128","author":"Kruisselbrink","year":"2019","journal-title":"Anesth Analg"},{"key":"R18-20260331","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bjae.2019.03.003","article-title":"Perioperative point-of-care gastric ultrasound.","volume":"19","author":"El-Boghdadly","year":"2019","journal-title":"BJA Educ"},{"issue":"suppl 1","key":"R19-20260331","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jcpt.13225","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes.","volume":"45","author":"Trujillo","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"R20-20260331","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2146\/ajhp050459","article-title":"Exenatide.","volume":"63","author":"Bray","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R21-20260331","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12630-023-02550-y","article-title":"Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!","volume":"70","author":"Jones","year":"2023","journal-title":"Can J Anaesth"},{"key":"R22-20260331","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"R23-20260331","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bja.2024.01.001","article-title":"Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.","volume":"132","author":"van Zuylen","year":"2024","journal-title":"Br J Anaesth"},{"key":"R24-20260331","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"key":"R25-20260331","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/anae.16601","article-title":"Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis.","volume":"80","author":"Elkin","year":"2025","journal-title":"Anaesthesia"},{"key":"R26-20260331","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1213\/ANE.0000000000007110","article-title":"Assessing full stomach prevalence with ultrasound following preoperative fasting in diabetic patients with dysautonomia: a comparative observational study.","volume":"139","author":"Sastre","year":"2024","journal-title":"Anesth Analg"},{"key":"R27-20260331","doi-asserted-by":"crossref","first-page":"e2231982","DOI":"10.1001\/jamanetworkopen.2022.31982","article-title":"Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity.","volume":"5","author":"Ghusn","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R28-20260331","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamacardio.2024.4657","article-title":"Semaglutide eligibility across all current indications for US adults.","volume":"10","author":"Shi","year":"2025","journal-title":"JAMA Cardiol"},{"key":"R30-20260331","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/anae.13233","article-title":"Peri-operative management of the surgical patient with diabetes 2015: association of Anaesthetists of Great Britain and Ireland.","volume":"70","author":"Barker","year":"2015","journal-title":"Anaesthesia"},{"key":"R31-20260331","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.mayocp.2020.10.002","article-title":"Preoperative management of endocrine, hormonal, and urologic medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R32-20260331","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.mayocp.2021.08.008","article-title":"Preoperative management of gastrointestinal and pulmonary medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R33-20260331","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ALN.0000000000004776","article-title":"American Society of Anesthesiologists Consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists.","volume":"140","author":"Joshi","year":"2024","journal-title":"Am Soc Anesthesiol"},{"key":"R34-20260331","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12630-024-02810-5","article-title":"Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.","volume":"71","author":"Chang","year":"2024","journal-title":"Can J Anaesth"},{"key":"R35-20260331","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet Med"},{"key":"R38-20260331","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.","volume":"20","author":"Kindel","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"R39-20260331","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","article-title":"Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association.","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:29:50Z","timestamp":1786112990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007764","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}